-
EP2275102
European procedure
Extract from the Register of European Patents
EP About this file: EP2275102
| EP2275102 - N3 alkylated benzimidazole derivatives as MEK inhibitors [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.06.2016 Database last updated on 31.08.2024 | Most recent event Tooltip | 03.06.2016 | No opposition filed within time limit | published on 06.07.2016 [2016/27] | Applicant(s) | For all designated states Array Biopharma, Inc. 3200 Walnut Street Boulder, CO 80301 / US | [2011/03] | Inventor(s) | 01 /
Wallace, Eli M. P.O. Box 1727 Lyons, CO 80540 / US | 02 /
Lyssikatos, Joseph P. Array Biopharma Inc. 3200 Walnut Street Boulder Colorado 80301 / US | 03 /
Hurley, Brian T. 3725 Birchwood Drive 22 Boulder, CO 80304 / US | 04 /
Marlow, Allison L. 2722 Juniper Avenue 57 Boulder, CO 80304 / US | [2015/31] |
| Former [2011/06] | 01 /
Wallace, Eli M. P.O. Box 1727 Lyons, CO 80540 / US | ||
| 02 /
Lyssikatos, Joseph P. Array Biopharma Inc. 3200 Walnut Street Boulder Colorado 80301 / US | |||
| 03 /
Hurley, Brian T. 3725 Birchwood Drive 22 Boulder, CO 80304 / US | |||
| 04 /
Marlow, Allison L. 2722 Juniper Avenue 57 Boulder, CO 80304 / US | |||
| Former [2011/03] | 01 /
Wallace, Eli M. P.O. Box 1727 Lyons, CO 80540 / US | ||
| 02 /
Lyssikatos, Joseph P. 1720 Eldorado Circle Superior, CO 80027 / US | |||
| 03 /
Hurley, Brian T. 3725 Birchwood Drive 22 Boulder, CO 80304 / US | |||
| 04 /
Marlow, Allison L. 2722 Juniper Avenue 57 Boulder, CO 80304 / US | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2015/31] |
| Former [2011/03] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Leopoldstrasse 4 80802 München / DE | Application number, filing date | 10011691.2 | 13.03.2003 | [2011/03] | Priority number, date | US20020364007P | 13.03.2002 Original published format: US 364007 P | [2011/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2275102 | Date: | 19.01.2011 | Language: | EN | [2011/03] | Type: | B1 Patent specification | No.: | EP2275102 | Date: | 29.07.2015 | Language: | EN | [2015/31] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.12.2010 | Classification | IPC: | A61K31/4184, C07D235/04, C07D235/06, A61P35/00 | [2011/03] | CPC: |
C07D235/06 (EP,US);
C07D235/08 (KR);
A61P1/00 (EP);
A61P1/18 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P31/00 (EP);
A61P35/00 (EP);
A61P35/04 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/08 (EP);
A61P9/10 (EP);
C07D235/24 (KR);
C07D401/06 (EP,US);
C07D401/12 (EP,US);
C07D401/14 (EP,US);
C07D403/04 (EP,US);
C07D403/06 (EP,US);
C07D403/12 (EP,US);
C07D405/06 (EP,US);
C07D413/04 (EP,US);
C07D413/06 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2015/31] |
| Former [2011/03] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR | Title | German: | N3-alkylierte Benzimidazolderivate als MEK-Inhibitoren | [2011/03] | English: | N3 alkylated benzimidazole derivatives as MEK inhibitors | [2011/03] | French: | Dérivés de benzimidazole d'alkylat N3 en tant qu'inhibiteurs de Mek | [2011/03] | Examination procedure | 14.07.2011 | Amendment by applicant (claims and/or description) | 14.07.2011 | Examination requested [2011/34] | 23.12.2011 | Despatch of a communication from the examining division (Time limit: M04) | 29.03.2012 | Reply to a communication from the examining division | 19.11.2014 | Communication of intention to grant the patent | 27.01.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 19.02.2015 | Communication of intention to grant the patent | 15.06.2015 | Fee for grant paid | 15.06.2015 | Fee for publishing/printing paid | 15.06.2015 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP03714148.8 / EP1482932 | EP09011388.7 / EP2130536 | Divisional application(s) | EP15177189.6 / EP3000810 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030714148) is 07.02.2007 | Opposition(s) | 02.05.2016 | No opposition filed within time limit [2016/27] | Fees paid | Renewal fee | 14.01.2011 | Renewal fee patent year 03 | 14.01.2011 | Renewal fee patent year 04 | 14.01.2011 | Renewal fee patent year 05 | 14.01.2011 | Renewal fee patent year 06 | 14.01.2011 | Renewal fee patent year 07 | 14.01.2011 | Renewal fee patent year 08 | 29.03.2011 | Renewal fee patent year 09 | 26.03.2012 | Renewal fee patent year 10 | 27.03.2013 | Renewal fee patent year 11 | 27.03.2014 | Renewal fee patent year 12 | 27.03.2015 | Renewal fee patent year 13 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [AD]WO0042022 (WARNER LAMBERT CO [US], et al) [AD] 1-20 * See the examples *; | [A]WO0105390 (WARNER LAMBERT CO [US], et al) [A] 1-20* See the examples;; claim - * | by applicant | EP0239362 | WO9005719 | EP0606046 | US5525625 | WO9627583 | WO9633172 | EP0780386 | WO9803516 | WO9807697 | WO9830566 | WO9833768 | WO9834918 | WO9834915 | WO9843960 | WO9901421 | WO9901426 | US5861510 | US5863949 | WO9929667 | EP0931788 | WO9952910 | WO9952889 | WO0018790 | WO0041505 | WO0042002 | WO0042003 | WO0041994 | WO0042022 | WO0042029 | WO0068201 | WO0105390 | WO0168619 | WO0206213 | - AHN ET AL., METHODS IN ENZYMOLOGY, (2001), vol. 332, pages 417 - 431 | - KHOKHLATCHEV, CELL, (1998), vol. 93, pages 605 - 615 | - AHN ET AL., MOLECULAR CELL, (2000), vol. 6, pages 1343 - 1354 | - LEWIS ET AL., ADV. CANCER RES., (1998), vol. 74, pages 49 - 139 | - KOHL ET AL., SCIENCE, (1993), vol. 260, pages 1834 - 1837 | - DAVIES, H. ET AL., NATURE, (2002), vol. 417, pages 949 - 954 | - HOSHINO, R. ET AL., ONCOGENE, (1999), vol. 18, pages 813 - 822 | - SEBOLT-LEOPOLD, NATURE-MEDICINE, (1999), vol. I, no. 7, pages 810 - 816 | - MILELLA ET AL., J CLIN INVEST, (2001), vol. 108, no. 6, pages 851 - 859 | - ADVARICED DRIIG DELIVERY REVIEWS, (1996), vol. 19, page 115 | - J. MED CHEM., (1996), vol. 39, page 10 | - AHN ET AL., SCIENCE, (1994), vol. 265, pages 966 - 970 | - TETRAHEDRON LETT., (1981), vol. 22, page 1287 | - ORG. CHEM., (1963), vol. 28, page 1604 | - HETEROCYCLIC CHEM., (2000), vol. 37, pages 827 - 830 | - J. ORG. CHEM., (1988), vol. 53, page 4131 | - TETRAHEDRON, (1996), vol. 52, page 1643 | - J. AM. CHEM. SOC., (1978), vol. 100, page 1481 | - ORG. SYNTH., (1992), vol. 69, page 96 | - TETRAHEDRON LETT., (1999), vol. 40, pages 8193 - 8195 | - WHITTEN ET AL., JOC, (1986), vol. 51, pages 1891 - 1894 | EP19970304971 | WO1998IB01113 | EP19990302232 | GB19990012961 | US19990148464 | EP19990308617 |